newsfilter
← Latest News
GlobeNewswire·

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results

Soquelitinib clinical development for atopic dermatitis advancing with Phase 1 cohort 4 positive data and initiation of Phase 2 trial during the quarter New immunologic and biomarker data supporting the potential for